Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Altered morphine-induced analgesia in neurotensin type 1 receptor null mice.

Roussy G, Beaudry H, Lafrance M, Belleville K, Beaudet N, Wada K, Gendron L, Sarret P.

Neuroscience. 2010 Nov 10;170(4):1286-94. doi: 10.1016/j.neuroscience.2010.08.016. Epub 2010 Aug 18.

2.

Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model.

Roussy G, Dansereau MA, Doré-Savard L, Belleville K, Beaudet N, Richelson E, Sarret P.

J Neurochem. 2008 May;105(4):1100-14. doi: 10.1111/j.1471-4159.2007.05205.x. Epub 2007 Dec 25.

3.

Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.

Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M.

Brain Res. 2006 Apr 14;1083(1):61-9. Epub 2006 Mar 10.

PMID:
16530171
4.

Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.

Roussy G, Dansereau MA, Baudisson S, Ezzoubaa F, Belleville K, Beaudet N, Martinez J, Richelson E, Sarret P.

Mol Pain. 2009 Jul 6;5:38. doi: 10.1186/1744-8069-5-38.

5.

The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratio.

Eiselt E, Côté J, Longpré JM, Blais V, Sarret P, Gendron L.

Eur J Pharmacol. 2019 Apr 5;848:80-87. doi: 10.1016/j.ejphar.2019.01.048. Epub 2019 Jan 29.

PMID:
30707956
6.

NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.

Smith KE, Boules M, Williams K, Richelson E.

Behav Brain Res. 2012 Jun 15;232(1):93-7. doi: 10.1016/j.bbr.2012.03.044. Epub 2012 Apr 5.

PMID:
22504145
7.

Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice.

Bredeloux P, Costentin J, Dubuc I.

Behav Brain Res. 2006 Dec 15;175(2):399-407. Epub 2006 Oct 30.

PMID:
17074405
8.

Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine.

Boules M, Johnston H, Tozy J, Smith K, Li Z, Richelson E.

Behav Pharmacol. 2011 Sep;22(5-6):573-81. doi: 10.1097/FBP.0b013e3283474a3a.

PMID:
21691202
9.

Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice.

Weibel R, Reiss D, Karchewski L, Gardon O, Matifas A, Filliol D, Becker JA, Wood JN, Kieffer BL, Gaveriaux-Ruff C.

PLoS One. 2013 Sep 12;8(9):e74706. doi: 10.1371/journal.pone.0074706. eCollection 2013.

10.

dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.

Wu HE, Sun HS, Terashivili M, Schwasinger E, Sora I, Hall FS, Uhl GR, Tseng LF.

Eur J Pharmacol. 2006 Feb 15;531(1-3):103-7. Epub 2006 Jan 30.

PMID:
16445907
11.

Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.

Pacheco Dda F, Klein A, Perez AC, Pacheco CM, de Francischi JN, Reis GM, Duarte ID.

Br J Pharmacol. 2009 Sep;158(1):225-31. doi: 10.1111/j.1476-5381.2009.00310.x. Epub 2009 Jul 7.

12.

NT69L, a novel analgesic, shows synergy with morphine.

Boules M, Shaw A, Liang Y, Barbut D, Richelson E.

Brain Res. 2009 Oct 19;1294:22-8. doi: 10.1016/j.brainres.2009.07.086. Epub 2009 Aug 3.

PMID:
19651107
14.

Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia.

Desroches J, Bouchard JF, Gendron L, Beaulieu P.

Neuroscience. 2014 Mar 7;261:23-42. doi: 10.1016/j.neuroscience.2013.12.030. Epub 2013 Dec 21.

15.

The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.

da Fonseca Pacheco D, Klein A, de Castro Perez A, da Fonseca Pacheco CM, de Francischi JN, Duarte ID.

Br J Pharmacol. 2008 Jul;154(5):1143-9. doi: 10.1038/bjp.2008.175. Epub 2008 May 12.

16.

Lack of a rewarding effect and a locomotor-enhancing effect of the selective μ-opioid receptor agonist amidino-TAPA.

Mizoguchi H, Watanabe C, Osada S, Yoshioka M, Aoki Y, Natsui S, Yonezawa A, Kanno S, Ishikawa M, Sakurada T, Sakurada S.

Psychopharmacology (Berl). 2010 Oct;212(2):215-25. doi: 10.1007/s00213-010-1946-0. Epub 2010 Aug 4.

PMID:
20683583
17.

Involvement of NTS2 receptors in stress-induced analgesia.

Lafrance M, Roussy G, Belleville K, Maeno H, Beaudet N, Wada K, Sarret P.

Neuroscience. 2010 Mar 17;166(2):639-52. doi: 10.1016/j.neuroscience.2009.12.042. Epub 2009 Dec 24.

PMID:
20035838
18.
19.

The heparin binding growth factors midkine and pleiotrophin regulate the antinociceptive effects of morphine through α(2)-adrenergic independent mechanisms.

Gramage E, Martín YB, Herradon G.

Pharmacol Biochem Behav. 2012 May;101(3):387-93. doi: 10.1016/j.pbb.2012.02.001. Epub 2012 Feb 10.

PMID:
22342918
20.

Contribution of GIRK2-mediated postsynaptic signaling to opiate and alpha 2-adrenergic analgesia and analgesic sex differences.

Mitrovic I, Margeta-Mitrovic M, Bader S, Stoffel M, Jan LY, Basbaum AI.

Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):271-6. Epub 2002 Dec 20.

Supplemental Content

Support Center